Abstract The probiotic potential of Lactobacillus plantarum and Lactobacillus fermentum strains, capable of overproducing riboflavin, was investigated. The riboflavin production was quantified in co-cultures of lactobacilli and human intestinal epithelial cells, and the riboflavin overproduction ability was confirmed. When milk and yogurt were used as carrier matrices, L. plantarum and L. fermentum strains displayed a significant ability to survive through simulated gastrointestinal transit. Adhesion was studied on both biotic and abiotic surfaces. Both strains adhered strongly on Caco-2 cells, negatively influenced the adhesion of Escherichia coli O157:H7, and strongly inhibited the growth of three reference pathogenic microbial strains. Resistance to major antibiotics and potential hemolytic activity were assayed. Overall, this study reveals that these Lactobacillus stains are endowed with promising probiotic properties and thus are candidates for the development of novel functional food which would be both enriched in riboflavin and induce additional health benefits, including a potential in situ riboflavin production, once the microorganisms colonize the host intestine.
Introduction
Probiotics are defined as live microorganisms which confer health benefits on the host when ingested in adequate amounts (FAO/WHO 2002; Morelli 2000) . The health-promoting activities exerted by probiotics on humans include the modulation of immunological, digestive, and respiratory functions and the prevention of infectious disease (FAO/WHO 2001) . Most of the probiotics so far identified belong to Bifidobacterium and Lactobacillus genera, and selected strains of such groups are present in many probiotic and functional food products and in dietary supplementations (Vinderola et al. 2005; Holzapfel et al. 1998) . Members of the Lactobacillus genus occur in a variety of niches, including plant material, fermented foods, and diverse parts of the animal body. In particular, lactobacilli are part of the natural human gut microbiota, and several commensal species of such groups have gained attention for their positive impact on the health of the host (FAO/WHO 2001; van Baarlen et al. 2013) .
In order to be defined as a probiotic, a microorganism must possess various attributes, including safety for human consumption, the capability to survive the gastrointestinal tract, to adhere to enterocytic cells and colonize the intestine, to reinforce the intestinal epithelial barrier, and to modulate gutassociated lymphoid tissue (GALT) (Marteau et al. 2001; Patel and Lin 2010) . Resistance to the high gastric acidity and to the intestinal environment allows a greater number of viable beneficial microorganisms to reach the lower gut, which is the main target organ of probiotic action. Furthermore, the ability to adhere to intestinal epithelial cells guarantees an intimate contact between enterocytes and probiotic microorganisms and thus positively influences (i) intestinal cell functions, (ii) gut microbiota composition, and (iii) host immune response. Microbial survival in the human gastrointestinal tract can be predicted and evaluated in vitro using models that mimic the gastrointestinal transit of ingested food (Bove et al. 2013; van Bokhorst-van de Veen et al. 2012 ). Cultures of enterocyte-like cells, such as Caco-2 cells, from human colon adenocarcinoma, are routinely used as in vitro model to study the mechanisms underlying host-probiotic interaction at the intestinal level, including bacterial adhesion to the gut epithelium (Lee et al. 2000) . Several studies on potential probiotic strains also consider their ability to modulate the expression of host genes involved in the immune response, apoptosis, and inflammatory processes (Delcenserie et al. 2008; Maccaferri et al. 2012) . A beneficial effect on the microbial equilibrium in the human intestine is another valuable probiotic trait. Indeed, some probiotics can directly compete against pathogenic bacteria for host epithelial cell receptors and/or produce antimicrobial compounds, i.e., bacteriocins, thus controlling colonization and limiting the proliferation of detrimental microbial species in the gut (Riley and Gordon 1999; Koo et al. 2012; Bove et al. 2013) . A further desirable feature of probiotics is their capability to synthetize compounds, such as vitamins or short-chain fatty acids, that can be helpful both to human and microbiota metabolisms (Dunne et al. 2001; Hooper et al. 2002) , by supplementing insufficient food intakes of these compounds and preventing the negative consequences of unbalanced diets (LeBlanc et al. 2011; Rossi et al. 2011) .
Riboflavin (vitamin B 2 ) plays a key role in metabolism as it is the precursor of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) (Capozzi et al. 2012; Burgess et al. 2006a ). Since humans cannot synthesize riboflavin, its dietary supplementation is essential (LeBlanc et al. 2010b ). Nevertheless, a certain amount of riboflavin can even be supplied endogenously by some microbes residing in the large intestine (Hill 1997) . The identification of microbial strains that exhibit a combination of probiotic characteristics and riboflavin overproduction would represent the opportunity to develop functional foods possessing probiotic properties, high riboflavin content, and with the potential to deliver viable microorganisms that can synthesize riboflavin directly in the intestine (Burgess et al. 2004; van Loon et al. 1996) .
In this study, we assayed the potential probiotic activity of Lactobacillus plantarum CECT 8328 and Lactobacillus fermentum CECT 8448 which were selected for their ability to overproduce riboflavin in a chemically defined medium (CDM) and in bread (Russo et al. 2014) . First, their riboflavin overproduction ability was tested in an in vitro model of the intestinal environment, i.e., cocultures of the lactobacilli strains and Caco-2 cells. Then, the survival of the tested strains was evaluated by exposure to an in vitro system simulating passage through the human gastrointestinal tract. Adhesion on Caco-2 monolayers and on an abiotic surface was also analyzed. Moreover, the strains were investigated for their ability to counteract pathogen growth and pathogen adhesion, on epithelial cells. The probiotic potential of the isolates was compared with that of reference probiotic lactobacilli.
Material and methods

Bacterial strains, human cells, and growth conditions
The lactobacilli used in this work were L. plantarum WCFS1 (Kleerebezem et al. 2003) , Lactobacillus acidophilus LA5 (Chr. Hansen, Hörsholm, Denmark) and the previously described riboflavin-overproducing L. fermentum strain (Russo et al. 2014) . In addition, a new overproducing strain of L. plantarum previously selected from sourdough (Russo et al. 2014 ) was used. Strains were deposited to the Spanish Type Culture Collection (CECT, Valencia, Spain) and named CECT 8328 (L. plantarum) and CECT 8448 (L. fermentum). Lactobacilli were propagated in de Man Rogosa Sharpe (MRS, Oxoid, Basingstoke, UK) (pH 6.2) and incubated at 30°C. For L. acidophilus LA5, MRS medium was supplemented with 0.1 % Tween and 0.05 %L-cysteine (Merck, Darmstad, Germany) and incubation was performed at 37°C. Bacteria were routinely harvested when cultures reached the mid-exponential phase (OD 600 nm 1, corresponding to a concentration of 2-8×10 8 CFU mL −1 ).
Then, the cultures were centrifuged (1,500×g, 10 min) and resuspended in appropriate solutions, depending on the assay, as described below. The bacterial pathogens used in this study were Listeria monocytogenes CECT 4032, Salmonella enteritidis CECT 409, and Escherichia coli O157:H7 CECT 4267. All pathogens were grown in tryptone soy broth (TBS, Oxoid) and incubated at 37°C.
Human adenocarcinoma colon cells Caco-2 were cultured in Dulbecco's Modified Eagle Medium (DMEM, SigmaAldrich, St. Louis, MO, USA) supplemented with 10 % (v/v) heat inactivated fetal bovine serum (FBS), 2 mML-glutamine, 100 U mL −1 penicillin, and 100 μg mL −1 streptomycin, at 37°C, in an atmosphere containing 5 % CO 2 . Caco-2 cells were seeded at the concentration of 1.2×10 4 cells/well in 96-well plates for the adhesion assay and at the concentration of 2×10 5 cells/well in 24-well plates for the riboflavin production assay. The growth medium was replaced three times per week, and 24 h before each assay, it was replaced with absolute DMEM, without any supplements. Cells were grown to form differentiated and steady epithelial/enterocytelike monolayers for 15 days.
Identification of L. plantarum CECT 8328 as a new riboflavin overproducing strain and production of riboflavin in a co-culture approach Selection of L. plantarum CECT 8328 riboflavinoverproducing strain, riboflavin extraction, and quantification in a CDM medium were performed as already reported (Russo et al. 2014) .
The ability of L. plantarum CECT 8328 and L. fermentum CECT 8448 to overproduce riboflavin in co-culture of lactobacilli and Caco-2 cells was examined according to the procedure of Russo et al. (2012b) . Bacterial cells (OD 600nm 1) were resuspended in absolute DMEM and incubated with Caco-2 (ratio 1,000:1, bacteria to Caco-2 cells) for 8 h, at 37°C, in a humidified atmosphere with 5 % CO 2 . Caco-2 cells incubated in DMEM without any microbial inocula were used as a control. After incubation, the medium was collected and the riboflavin was extracted and quantified according to Jakobsen (2008) . Briefly, 5-mL samples were mixed to 25 mL 0.1 M HCl, autoclaved at 121°C for 30 min, and cooled at room temperature. Then, pH was adjusted to 4.5 with 4 M sodium acetate and 5 mL of solution containing α-amylase (420 U), papain (12 U), acid phosphatase (22 U), and 0.1 % of glutathione (all from Sigma-Aldrich) were added. The enzymatic hydrolysis was facilitated by placing samples in an ultrasonic bath for 1 h. Afterward, each sample was diluted to 50 mL with 0.01 M HCl. The riboflavin quantification was carried out by HPLC analysis (Agilent-1100 Series, Palo Alto, CA, USA). All samples were filtered through 0.45-and then 0.20-μm filters. Chromatography was performed using Zorbax Eclipse Plus C18 (4.6×150 mm, 5 μm i.d.) analytical column with a Zorbax ODS pre-column (4.6× 12.5 mm, 5 μm i.d.) (Agilent Technologies) and methanol/ water (35:65v/v) mixture as mobile phase. Detection of the eluate was performed by fluorescence at an excitation wavelength of 440 nm and an emission wavelength of 520 nm.
L. plantarum and L. fermentum CECT 8447 (Russo et al. 2014 ) parental non-riboflavin overproducing strains were used as controls to determine the amount of riboflavin produced by L. plantarum CECT 8328 and L. fermentum CECT 8448 strains.
Tolerance of L. plantarum CECT 8328 and L. fermentum CECT 8448 to a simulated gastrointestinal system Bacterial cells were resuspended in three different carrier matrices: (i) saline solution (NaCl 8.5 g L −1 ), (ii) reconstituted milk powder in sterilized water (150 g L −1 ) (Humana One, GmbH, Herford, Germany), and (iii) commercial white yogurt used without dilutions. Both reconstituted milk and yogurt were subjected to thermal treatment (72°C for 20 min), and the absence of any bacterial contamination was checked by plating on MRS agar plates before the gastrointestinal assay. The simulated gastrointestinal transit was adapted from a system previously described (Bove et al. 2013) . Briefly, bacterial suspension was subjected to an oral stress step incubating for 5 min with 150 mg L −1 lysozyme (Sigma-Aldrich) and adjusting to pH 6.0. Subsequently, pepsin (3 g L −1 ) (Sigma-Aldrich) was added, and the pH value was progressively reduced in order to mimic the gastric compartment. Intestinal stress was performed by adjusting the pH value to 6.5 and by addition of bile salts (3 g L −1 ) and pancreatin (1 g L −1 ) (all from Sigma-Aldrich). In relation to the previously designed gastrointestinal system (Bove et al. 2013) , in the present study, only the oral compartment, gastric steps corresponding to pH values of 3.0 and 2.0 and subsequent intestinal transits (small and large intestine sectors) were used for the evaluation of bacterial survival. Dilutions from control and treated samples of each strain were plated on MRS agar, CFU were counted, and percent survival was determined with respect to unstressed control.
In vitro adhesion assay
Adhesion assays were performed on Caco-2 cell monolayers according to Russo et al. (2012a) . Bacterial cells were resuspended in absolute DMEM and incubated with Caco-2 cells for 1 h, at 37°C, with 5 % CO 2 (ratio 1,000:1, bacteria to Caco-2 cells). The percentage of adhesion by lactobacilli was determined by plating appropriate dilutions of the bacterial suspensions from control and test wells on MRS agar and subsequent CFU counting. The ability of the analyzed lactobacilli to inhibit the adhesion of E. coli O157:H7 to Caco-2 cells was also investigated. E. coli cells from mid-exponential phase cultures (OD 600nm 1, corresponding to 8×10 8 CFU/mL) were added to Caco-2 cells in a ratio of 1,000:1, likewise the lactobacilli. Three different types of experiments were performed: (i) competitive adhesion, i.e., simultaneously incubating Caco-2 cells with E. coli and each of the Lactobacillus strains for 1 h; (ii) inhibition of adhesion, i.e., pre-incubating Caco-2 cells with the specific lactobacillus strain for 1 h, then adding E. coli and further incubating for 1 h; (iii) displacement, i.e., pre-incubating Caco-2 cells with E. coli for 1 h, then adding lactobacilli and further incubating for 1 h (Koo et al. 2012; Candela et al. 2008; Gagnon et al. 2004 ). The inhibition of pathogen adhesion was determined by a quantitative PCR-based method, according to Candela et al. (2005) . Results were expressed as a relative adhesion level with respect to the adhesion observed when E. coli O157:H7 was tested alone (control sample). Adhesion rate of E. coli was determined by quantitative realtime PCR (qPCR) analysis on samples obtained from test and control wells.
Antimicrobial activity assay
To examine the antimicrobial activity of the lactobacilli strains, an agar spot test was used, as described by Gaudana et al. (2010) . Briefly, 5 μL of each of the overnight cultures of the lactobacilli was spotted on MRS agar and incubated for 24 h at 37°C to allow growth. L. monocytogenes CECT 4032, S. enteritidis CECT 409, and E. coli O157:H7 CECT 4267 were grown overnight in TSB, and 150 μL of each pathogenic bacterial strain was mixed with 15 mL of TSB soft agar (containing 0.6 % agar, w/v) and poured over MRS agar plates containing the developed colonies of the lactobacilli. Plates were incubated for 24 h, and the radii of the inhibition zones were measured.
RNA extraction, cDNA synthesis, and qPCR analysis A qPCR strategy was also employed to determine the percentage of E. coli O157:H7 adhesion on Caco-2 cells. To quantify adherent E. coli cells by real-time PCR, cell suspensions from adhesion assays were heat treated (10 min, 95°C) and then chilled on ice. Aliquots (3 μL) were then mixed with 1× iTaq supermix (Bio-Rad, Hercules, CA, USA), H flagellar antigen specific gene (fliC H7) TaqMan probe (200 nM), and primers (500 nM each) (Perelle et al. 2004 ). Reactions were cycled in an ABI 7300 instrument (Applied Biosystems, Foster City, CA, USA) as follows: initial denaturation at 95°C for 10 min and 45 cycles of denaturation at 95°C for 10 s, annealing at 60°C for 30 s, and fluorescence acquisition (FAM) at 72°C for 30 s. Each PCR assay included duplicate reactions on DNA samples (i.e., heat-treated cell suspensions), on no template (negative) control and on internal standards, i.e., serial dilutions of E. coli suspension (corresponding to a concentration) ranging from 1×10 4 to 1×10 8 CFU/mL, to generate a reference standard curve which was used for quantification.
Hemolytic activity, antibiotic resistance, and biofilm formation assays Lactobacilli were assayed for hemolytic activity by spotting cultures onto Columbia agar plates (Oxoid) containing 5 % (w/v) of defibrinated human blood from healthy donors. Plates were incubated at 30°C for 48 h (Maragkoudakis et al. 2006 ) and analyzed for α-, β-, and γ-hemolytic activity. L. monocytogenes was used as a positive control. Lactobacilli were also tested for resistance against several antibiotics as described by EFSA (2012). Antibiotics were ampicillin (0.5, 1, 2, and 4 mg L ).
The ability to produce biofilms on glass surface was assayed according to Vergara-Irigaray et al. (2009) . Cultures of the lactobacilli strains were inoculated in fresh MRS broth (2 %v/v) and incubated for 24 and 48 h at 37°C, in an orbital shaker (200 rpm). Biofilm rings were washed twice with distilled water and then stained with crystal violet (5 g L −1 , 0.5 %w/v). The biofilms were solubilized with acetic acid (30 % v/v), and optical density (OD) was measured at 570 nm.
Statistical analysis
Each reported finding represents the mean ± SD of three different experiments. Data were analyzed by Student's t test using the IBM SPSS Statistics 21.0 software program (IBM, Armonk, NY, USA). p<0.05 and p<0.005 were considered as statistically significant.
Results
Overproduction of riboflavin by L. plantarum CECT 8328
L. plantarum CECT 8328 was selected as a roseoflavinresistant strain by exposure to gradually increasing concentrations of roseoflavin (Russo et al. 2014) . Then, the ability of this strain to overproduce riboflavin, compared to the parental strain, was investigated in CDM medium. The riboflavin production by L. plantarum CECT 8328 was 3.33 mg L −1 , while no riboflavin was detected in the medium of the parental strain (Fig. 1) . To our knowledge, and among the L. plantarum strains identified so far, L. plantarum CECT 8328 is the highest riboflavin producer currently available (Capozzi et al. 2012) .
Furthermore, we investigated the capability of L. plantarum CECT 8328 and L. fermentum CECT 8448 to synthetize riboflavin in co-culture with intestinal Caco-2 cells as reported in Fig. 2 . Interestingly, riboflavin production was detected in the medium where L. plantarum CECT 8328 and L. fermentum CECT 8448 were inoculated. The concentrations of riboflavin were 397 ± 2 and 430 ± 4 μg L −1 for L. plantarum CECT 8328 and L. fermentum CECT 8448, respectively. In contrast, the riboflavin contents of the media inoculated with the L. plantarum and L. fermentum parental isolates were 117±14 and 192±25 μg L −1 , respectively.
Uninoculated DMEM medium contained a concentration of riboflavin of 322.9±24.3 μg L −1 , corresponding to the amount of riboflavin stated by the supplier (Fig. 2) . Therefore, our results showed that L. plantarum CECT 8328 and L. fermentum CECT 8448 have the capability to produce riboflavin, 3.4-fold and 2.2-fold higher than the non-roseoflavin-resistant isolates L. plantarum and L. fermentum strains.
Survival during the GI transit
The capability of L. plantarum CECT 8328 and L. fermentum CECT 8448 to tolerate the gastrointestinal (GI) tract conditions was investigated using an in vitro model that mimics the human digestive process through the oral cavity, the stomach, and intestine. Overall, our observations indicated a variable survival depending on strains, vehicle matrices, and GI steps (Fig. 3) . The bacterial viability of all strains, expressed as a percentage of survival with respect to untreated samples, was not influenced by oral stress using the different matrices. In contrast, bacterial survival was significantly reduced under gastric conditions in a pH-dependant manner. In saline solution survival decreased by about 3 and 6 log units, in the gastric sectors at pH 3.0 and 2.0, respectively, with no significant differences between the tested strains. Whereas, at the same steps, the reduction of bacterial survival was lower and approximately of 1-3 and 1-4 log units when tested in milk and yogurt, respectively. Under intestinal stresses, both small and large intestinal challenges, minor reductions of cell viability were found, in all considered matrices. In saline solution, the percentage of survival after the intestinal stress decreased by 4 to 6 log units, and there were no major differences between bacterial strains, except for L. acidophilus LA5, whose survival was mainly negatively compromised by intestinal conditions compared to other strains. In milk, the percentage of survival was reduced in a range of 3-4 log units, and no relevant differences were observed between bacterial strains.
Adhesion to Caco-2 cells
The ability of L. plantarum CECT 8328 and L. fermentum CECT 8448 to adhere to human enterocyte-like cells was assayed, and the results are shown in Fig. 4 . Both the tested isolates possessed a higher adhesion ability compared to the probiotic control strains (L. plantarum WCFS1 and L. acidophilus LA5), when the adhesion levels were expressed as a percentage (Fig. 4a) or as the absolute number of adherent bacteria on Caco-2 cell (Fig. 4b) . The percentage of adhesion to Caco-2 cells was around 16 and 17 % for L. plantarum CECT 8328 and L. fermentum CECT 8448, respectively, whereas L. plantarum WCFS1 and L. acidophilus LA5 adhesion levels were about 12 and 6 %, respectively (Fig. 4a) . The corresponding values of adherence expressed as the number of adherent bacteria on single Caco-2 cell (CFU/Caco-2) were as follows: 120±17 CFU/Caco-2 for L. plantarum CECT 8328, 163 ± 25 CFU/Caco-2 for L. fermentum CECT 8448, 94 ± 16 CFU/Caco-2 for L. plantarum WCFS1, and 11±7 CFU/Caco-2 for L. acidophilus LA5 (Fig. 4b) .
Influence of L. plantarum and L. fermentum on the adhesion ability of E. coli O157:H7
The ability of L. plantarum CECT 8328 and L. fermentum CECT 8448 to interfere with the adhesion of E. coli O157:H7 was quantified by real-time PCR. In the competition assay (between lactobacilli and pathogen), E. coli O157:H7 and the lactobacilli strains were co-incubated with Caco-2 cells (Fig. 5) . As shown in Fig. 5a , the adhesion ability of E. coli O157:H7 was significantly reduced by 1.4-fold or 1.6-fold, when coincubating with L. plantarum CECT 8328 or L. fermentum CECT 8448. L. plantarum WCF1 also produced a significant decrease (about 1.6-fold) of pathogen adhesion, whereas L. acidophilus LA5 did not display any significant effect on E. coli O157:H7 binding to enterocytes. When the lactobacilli strains were pre-incubated with Caco-2 cells for 1 h prior to inoculation with E. coli O157:H7 and then incubated for a further 1 h, a significant reduction of pathogen adhesion was observed for all the lactobacilli tested, ranging from 2.2-fold to 4.8-fold (Fig. 5b) . The lowest number of adherent E. coli O157:H7 cells was detected when pre-incubation was performed with L. plantarum WCFS1, although comparable decreases in pathogen adhesion were observed with all the other tested lactobacilli. When Caco-2 cells were first pre-incubated with Escherichia coli O157:H7 and lactobacilli were sequentially added, the adhesion levels of E. coli O157:H7 (Fig. 5c ) were significantly increased (from 2.0-fold to 5.4-fold) with respect to control conditions (no lactobacilli added).
Antimicrobial activity, hemolytic activity, and antibiotic resistance L. plantarum CECT 8328 and L. fermentum CECT 8448 were investigated for a potential antagonistic activity against the pathogens L. monocytogenes, S. enteritidis, and E. coli O157:H7. This was evaluated by measuring the growth inhibition halos produced on agar plates by the tested lactobacilli strains. As reported in Table 1 , L. plantarum CECT 8328 and L. fermentum CECT 8448 were able to inhibit L. monocytogenes, S. enteritidis, and E. coli O157:H7.
The strains analyzed presented γ-hemolytic activity (i.e., no hemolysis) on Columbia blood agar plates, unlike L. monocytogenes that was used as positive control and exhibited β-hemolytic activity (Table 1) . Moreover, L. plantarum CECT 8328 and L. fermentum CECT 8448 strains were tested for antibiotic resistance against a representative range of clinical antibiotics. However, all the analyzed strains were susceptible to the tested antibiotics, with L. plantarum CECT 8328 able to grow only in the presence of 2 mg L −1 of chloramphenicol (data not shown).
Biofilm production
The ability of L. plantarum WCFS1, L. acidophilus LA5, L. plantarum CECT 8328, and L. fermentum CECT 8448 strains to form biofilms on a smooth glass surface was evaluated. All the strains analyzed were able to adhere to glass surface as measured by absorbance spectrophotometry (Fig. 6) 
Discussions
Lactic acid bacteria (LAB) are a group of microorganisms that are widely used in industry as starter cultures for the production of fermented foods. Besides their fermentative capacities, LAB can improve safety, shelf life, nutritional value, flavor, and overall quality of the product. In addition, LAB may exert a range of properties beneficial to health, and for this reason, they are used as probiotic microorganisms in a variety of functional products (van Baarlen et al. 2013 ). We previously selected and characterized a strain of L. fermentum able to overproduce riboflavin in CDM media or during bread fermentation (Russo et al. 2014 ). Additionally, several L. plantarum strains were selected from the same matrix (sourdough) as potential riboflavin producers. In this study, we investigated the riboflavin overproduction of L. plantarum CECT 8328, one of the strains selected, and we found that this strain was able, in CDM media, to produce riboflavin with a concentration of about 3.3±0.13 mg L −1 (Fig. 1) .
L. plantarum CECT 8328 and L. fermentum CECT 8448 strains were analyzed for their probiotic potential. Initially, we observed that L. plantarum CECT 8328 and L. fermentum CECT 8448 were able to produce higher amounts of riboflavin compared to their parental isolates (3.4-fold and 2.2-fold, respectively) as also occurred in a co-culture system with intestinal Caco-2 cells. Furthermore, we noted that the concentration of riboflavin in the Caco-2 co-culture systems with both the parental strains decreased by about 60 and 36 % with respect to the internal control (uninoculated DMEM medium), presumably due to the utilization of riboflavin by the LAB strains. However, when L. plantarum CECT 8328 and L. fermentum CECT 8448 were inoculated in the medium, the riboflavin content increased by about 26 and 36 % compared to the internal control (Fig. 2) . The uptake of riboflavin from the growth medium occurs apparently via a facilitated diffusion mechanism mediated by protein RibU. that possess the riboflavin biosynthesis operon. A regulatory region called the RFN element is conserved upstream of the ribU genes (Burgess et al. 2006b ). The rib leader region of L. plantarum CECT 8328 and L. fermentum CECT 8448 showed point mutations at two neighboring locations of the RFN element (Russo et al. 2014) . These mutations could explain the low, or absent, riboflavin uptake and the consequent enhancement of the external riboflavin concentration due to the overproduction. In the case of the parental L. plantarum and L. fermentum, a negative feedback regulation of the riboflavin operon may occur due to the riboflavin available in the medium. Thus, these bacteria decreased the total amount of external riboflavin due to their metabolic requirement. Other authors have also indicated that a strain of Lactococcus lactis consumes riboflavin from the growth medium, while a derivative strain with a deletion in the ribU region does not use the riboflavin from the medium probably due to a non-functional uptake mechanism (Burgess et al. 2006b ).
According to our results, L. plantarum CECT 8328 and L. fermentum CECT 8448 may be able to produce riboflavin in the human intestinal environment and thus make this vitamin available to the host. Orally delivered probiotics must be resistant to acidic gastric juices, to bile salts, and to the action of digestive enzymes, in order to establish themselves in the lower gut and thus guarantee their beneficial effects. Ingested food is subjected to a range of pH during the gastric transit depending on various factors, including food type and gastric juice secretion (Bezkorovainy 2001) . The probiotic potential Fig. 5 Influence of lactobacilli on the adhesion of E. coli O157:H7 to Caco-2 cells. In the co-incubation trial, probiotics and E. coli O157:H7 were co-incubated with Caco-2 cells; in the probiotic pre-incubation trial, probiotics were pre-incubated with Caco-2 cells and then E. coli O157:H7 was added; in the pathogen pre-incubation trial, E. coli O157:H7 was preincubated with Caco-2 cells and then probiotics were added. The inhibition of pathogen adhesion was determined by a quantitative PCRbased method and expressed as a relative level with respect to the adhesion observed when E. coli O157:H7 was tested alone (control sample). Values represent mean ± standard deviation of three different experiments. Statistical analyses were carried out by Student's t test and significant differences are relative to control sample (*p<0.05 and **p < 0.005). E. coli O157:H7, E. coli; L. plantarum WCFS1, LpWCFS1; L. acidophilus LA5, La5; L. plantarum CECT 8328, Lp8328; L. fermentum CECT 8448, Lfm8448 Table 1 Antimicrobial and hemolytic activity exhibited by the examined lactobacilli. According to Gaudana et al. (2010) , the lactobacilli strains producing inhibition zones of 1, 2, 2-5, and more than 5 mm were classified as no (+/−), mild (+), strong (++), and very strong (+++) inhibitors. L. plantarum WCFS1, LpWCFS1; L. acidophilus LA5, La5 L. monocytogenes E. coliO157:H7 S. enteritidis Hemolytic activity
of a microorganism can be evaluated by in vitro models that simulate the physical-chemical conditions encountered in the human GI tract (Bove et al. 2013 ). The food matrix should protect the delivered microbe from the GI hostile environment, sustaining its growth and activity. Commonly used food vehicles are fermented or fresh milks, although alternative carriers are also being investigated (Pitino et al. 2012 ). In our case, the survival of L. plantarum CECT 8328 and L. fermentum CECT 8448 under in vitro GI stresses was compared with that of two well-known probiotics, L. plantarum WCFS1 and L. acidophilus LA5 (Fig. 3) . In order to evaluate the effects of carrier matrix on bacterial survival, L. plantarum CECT 8328 and L. fermentum CECT 8448 were exposed to simulated GI conditions using different vehicles, including milk and yogurt which are frequently used in the preparation of probiotic foods. The bacterial viability of all strains analyzed and in all the tested matrices was significantly influenced by acid conditions (pH 3.0 and pH 2.0). Similar results have been reported (Bove et al. 2013; Fernández de Palencia et al. 2008; Both et al. 2010; Maragkoudakis et al. 2006) , confirming that low pH is the strongest challenge for probiotic microorganisms and corroborating the necessity to select probiotic strains that are able to tolerate the highly acidic environments of the stomach. Under intestinal stresses, we generally found minor reductions of cell viability, apparently due to the lower influence of bile and pancreatin on bacterial survival and to the beneficial effect of the higher pH value. Other studies have also indicated that bacterial viability is less affected by bile salts than by acid stress, suggesting a possible recuperation of viability during the intestinal passage (Maragkoudakis et al. 2006; Fernández et al. 2003) . In all the trials we observed a major susceptibility of bacterial strains to acid stress at pH 2.0 and a subsequent recovery of the bacterial viability after the intestinal stress step. Such recovery, about 1 or 2 log units, could not be explained by a normal growth rate; therefore, we assume that part of the bacterial population exposed to pH 2.0 was in a viable but non-cultivable (VBNC) state. Under intestinal conditions, the bacterial cells could then turn into a cultivable form (Fernández de Palencia et al. 2008; Succi et al. 2005) , thereby accounting for the observed CFU increase. Moreover, Fernández de Palencia et al. (2008) suggested a possible formation of bacterial chains or aggregations during gastric challenge that could lead to a single colony on plates resulting in an underestimation of viable cells. The formation of chains and/or clumping could disappear during the intestinal transit.
A clear protective effect of the food matrix was observed when milk and, even more significantly, yogurt were used. This was indicated by the higher survival rates observed after the complete gastrointestinal transit and is probably due to the milk proteins that can shield bacterial cells exposed to acid stresses (Fernández de Palencia et al. 2008) . In milk, following the entire digestive process, L. plantarum CECT 8328 and L. plantarum WCFS1 showed higher percentages of viability compared to L. acidophilus LA5 and L. fermentum CECT 8448, although L. fermentum CECT 8448 exhibited a good tolerance to a pH value of pH 3.0. Moreover, our results suggest that when L. plantarum CECT 8328 is vehicled by yogurt, it has a pronounced ability to tolerate GI stress, comparable to that of L. acidophilus LA5, which is known to be acid tolerant and is commonly employed for the production of functional food (Fernández de Palencia et al. 2008) . Overall, the good tolerance to the GI tract conditions observed for the tested strains complies with the prerequisites of probiosis (Morelli 2000; de Vrese and Schrezenmeir 2008) . Moreover, the presence of a food matrix, i.e., milk and yogurt, commonly used to inoculate probiotic strains, has been proven to improve bacterial delivery to the distal segments of the intestine, thus enhancing the chance of colonization and related beneficial effects.
The ability of probiotic bacteria to adhere on intestinal cells is a feature that could potentiate the colonization of the intestine and is thus considered a key attribute of probiotic microorganisms (Piątek et al. 2012) . We have analyzed all strains for their adhesion ability, and we expressed the adhesion levels both as an absolute number of adherent bacteria on Caco-2 cells and as a percentage (Fig. 4) . Candela et al. (2005) proposed a classification of probiotics as nonadhesive, adhesive, and strongly adhesive, corresponding to less than 5, between 5 and 40, and more than 40 adherent CFU per Caco-2 cell respectively. On the basis of our results expressed as percentage of adhesion and following the definitions of Candela et al. (2005) , we classified L. plantarum CECT 8328 and L. fermentum CECT 8448 as strongly adhesive strains.
Furthermore, the ability of L. plantarum CECT 8328 and L. fermentum CECT 8448 strains to counteract E. coli O157:H7 adhesion was analyzed using three different approaches: (i) pathogen-probiotic co-incubation, (ii) probiotic pre-incubation, and (iii) pathogen pre-incubation assay (Fig. 5) . In the co-incubation trial, probiotic and pathogen were incubated at the same time on Caco-2 cells. L. plantarum CECT 8328 and L. fermentum CECT 8448 showed a pronounced capability to compete with the pathogen for the adhesion on the epithelial intestinal cells that could contribute to inhibit and/or decrease the infection process by the pathogen as already suggested elsewhere (Levine 1987; Weinstein et al. 1998) . Similarly, Lee et al. (2000) highlighted that the degree of competition is a strain-dependent characteristic and the ability to counteract pathogen adhesion probably depends on the affinity of bacterial adhesins for the stereo-specific receptors on epithelial cells (Lee et al. 2000) . Thus, each Lactobacillus strain should interfere with the adhesion of a restricted range of pathogens, against which it possesses greater affinity for the same binding sites of the intestinal surface.
In the probiotic pre-incubation assay, we investigated the ability of probiotics to exclude the binding of pathogens, in the case in which the probiotic is already adhered on the intestinal cells. Both probiotic strains reduced significantly the pathogen adhesion. The inhibition profile of the exclusion assay was similar to that of the competitive assay, except for L. acidophilus LA5. Indeed, although the mechanism is not yet elucidated, the exclusion of pathogens from intestinal sites by lactobacilli could be connected to a competition process (Lee et al. 2000) . In the case of co-incubation with L. acidophilus LA5, the number of adherent E. coli O157:H7 CFU was much higher. Contrarily, in the preincubation trial, L. acidophilus LA5 showed an appreciable capability to exclude the pathogen, and, overall, the pathogen adhesion level was consistently reduced compared to the coincubation trial. According to our data, lactobacilli have greater capability to counteract pathogen adhesion when they have already established adhesion to the epithelial surface, and this is probably achieved by steric hindrance mechanisms (Koo et al. 2012; Sanchez et al. 2008) .
Furthermore, we evaluated the potential inhibitory effect of probiotics on pathogen when the latter is already adherent on the enteric surface. Interestingly, our observations suggest that probiotic strains increased the adhesion levels of E. coli O157:H7 (Fig. 5) . However, these findings may be due to an insufficient incubation time. The displacement of pathogens by lactobacilli could take a longer time, presumably more than 1 h, as already suggested by Lee et al. (2003) . Therefore, our results suggest that when probiotic bacteria are already settled on the intestinal epithelial surface (e.g., probiotic pre-incubation trial) or reach the enterocytes at the same time with the enteropathogen (e.g., co-incubation trial), their ability to interfere with pathogen adhesion is clearly displayed. Thus, a regular consumption over time of probiotic bacteria could contribute to the formation of a protective barrier against pathogens. In contrast, the use of probiotics against pathogens such as E. coli O157:H7 may give unfavorable results when pathogens are already established on the intestinal cells, probably due to the slow action of the probiotics investigated. Elmer et al. (2001) used the term "living drugs" to define the probiotic strength to act as a preventive drug in the prophylaxis of some gastrointestinal disorders, including microbial-associated diarrhea, in the treatment of vaginal and urinary tract infections and, moreover, in immune disorders, lactose intolerance, hypercholesterolemia, food allergy, bladder and colon cancer (Mombelli and Gismondo 2000) . The therapeutic use of probiotics, although they act slower than drugs, has been evaluated, and the results confirmed the potential attractiveness of these "low cost-slow action-high effect drugs".
The antimicrobial activity of probiotic microorganisms was evaluated measuring the growth inhibition halos on agar plates when probiotic bacteria were grown with three pathogens. According to a previous classification, lactobacilli can be defined as strains of no, mild, strong, and very strong inhibition, when they produce inhibition zones of 1, 2, 2-5, and more than 5 mm, respectively (Gaudana et al. 2010) . On this basis, we would categorize L. plantarum CECT 8328 and L. plantarum WCFS1 as strong inhibiting strains toward all tested pathogens, whereas L. fermentum CECT 8448 was a strong inhibitor strain of the Gram-negative S. enteritidis and E. coli O157:H7 and a mild inhibitor of the Gram-positive L. monocytogenes. L. acidophilus LA5 had the ability to antagonize the growth of only L. monocytogenes, as it did not produce any significant inhibition zones against S. enteritidis and E. coli O157:H7 (Table 1) . Overall, L. plantarum CECT 8328 showed the strongest antagonism capability of all the analyzed Lactobacillus strains.
None of the tested strains presented hemolytic activity and neither antibiotic resistance ( Table 1) . As indicated by EFSA (2012), we categorized all bacteria strains as susceptible according to the microbiological cutoff value indications. These results confirm the GRAS status of lactobacilli strains and comply with the key attribute of safety required for probiotics (Salminen et al. 1998) .
Biofilm formation is the way by which several bacteria grow and counteract exogenous stresses. The adhesion of bacterial cells to cell tissue or other surfaces occurs by self-synthesized exopolysaccharides that ensure the biofilm stability (Rendueles et al. 2013 ). In the human orogastrointestinal tract, probiotic bacteria, but also pathogens, can be present as single or association cells, i.e., biofilm (Macfarlane and Dillon 2007) . The ability of probiotic microorganism to form biofilms could be advantageous, creating a closer cell-to-intestine interaction and hence beneficial effects to the host, including the reduction of pathogen biofilms (Söderling et al. 2011; Rendueles et al. 2013) . Comparing the ability of adhesion to abiotic (glass) and biotic (Caco-2 cells) surfaces, we observed that L. acidophilus LA5 showed a low capability to bond to either surface, while L. plantarum CECT 8328 was the best adherent strain forming strong biofilm and exhibiting a very good adhesion on intestinal cells. Conversely, L. fermentum CECT 8448 was the probiotic with the strongest adherent ability on Caco-2 cells, whereas its aptitude to form biofilm on a glass surface was mediocre (Fig. 6) .
Humans require a dietary intake of riboflavin, as they are unable to biosynthesize this vitamin. However, a relevant source of vitamin B 2 can arise from the anabolic activity of members of the gut microbiota (Hill 1997) . Taking into account recent animal trials, vitamin-producing probiotics, administered orally, could be used as an effective endogenous source of vitamins (Pompei et al. 2007; LeBlanc et al. 2010a ). Thus, the identification and development of vitaminproducing probiotics can be regarded as a promising perspective in the therapeutic application of probiotics. Indeed, selected microorganisms could both exert the beneficial effect of probiotics and provide an endogenous source of vitamins, thereby preventing the vitamin deficiencies associated with the onset of various pathologies (Rossi et al. 2011) .
In this study, two strains of Lactobacillus, previously selected for their ability to overproduce riboflavin either previously (Russo et al. 2014) or in the present work (L. plantarum CECT 8328), were investigated in order to assess their potential probiotic activity. Riboflavin overproduction was detected under conditions resembling the intestinal environment (i.e., lactobacilli and Caco-2 cell co-cultures). Survival to an in vitro OGI system was satisfactory, comparable to that of reference probiotics and particularly marked when yogurt was used as carrier matrix. Both strains exhibited a strong adherence on human enterocytelike cells, which suggests the potential for intestinal colonization. Biofilm assays indicated good adhesion ability even on abiotic surfaces. Moreover, the investigated strains were able to consistently hinder the intestinal adhesion of an enteropathogen and antagonize growth of three potential food-borne detrimental microbes. Similarly to the control probiotic strains, the investigated lactobacilli were devoid of β-hemolytic activity and antibiotic resistance.
Based on our findings, the investigated L. plantarum CECT 8328 and L. fermentum CECT 8448 strains possess the potential ability to survive the OGI transit, reach the intestine in a viable state, and there exert various probiotic activities, including the production of vitamin B 2 in the body compartment where it can be adsorbed.
The selection of appropriate lactobacilli strains with the above mentioned properties could be exploited to develop novel functional food which is both vitamin-enriched, thanks to the bacterial metabolism and, simultaneously, presents probiotic beneficial effects for the host health.
